ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,122, issued on Dec. 2, was assigned to MIRATI THERAPEUTICS INC. (Princeton, N.J.).
"Combination of palbociclib and adagrasib for lung cancer" was invented by James Gail Christensen (San Diego), Ruth Wei Aranda (San Diego), Lars Daniel Engstrom (Carlsbad, Calif.), Jill Hallin (San Diego) and Peter Olson (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to combination therapies for treating KRas G12C cancers. In particular, the present invention relates to methods of treating cancer in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a combination of a CDK 4/6...